Studies in hypertriglyceridaemia VI: Serum lathosterol concentration is raised in hypertriglyceridaemic non-diabetic males with hyperinsulinaemia

Journal of Internal Medicine

Volumn 245, Issue 3, 1999, Pages 247-252

  Asplund Carlson, A ^a   Lund, E ^a   Bjorkhem I ^a   Carlson, L A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body mass index; Hyperinsulinaemia; Hypertriglyceridaemia; Insulin sensitivity; Lathosterol

Indexed keywords

CHOLESTEROL; INSULIN; LATHOSTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; HUMANS; HYPERINSULINISM; HYPERTRIGLYCERIDEMIA; INSULIN; MALE; MIDDLE AGED;

EID: 0033001804     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1999.0436e.x     Document Type: Article

References (25)

1. 1 Austin MA. Plasma triglycerides and coronary heart disease. Arteriosclerosis and Thrombosis 1991; 11: 2-14.
2. 2 Carlson LA, Böttiger LE. Risk factors for ischemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985; 218: 207-11.
3. 3 Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm ischemic heart disease secondary prevention study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988; 223: 405-18.
4. 4 Kempen HJM, Glatz JFC, Gevers Leuven JA, van der Voort HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lip Res 1988; 29: 1149-55.
5. 5 Miettinen TA. Biosynthesis of cholesterol. Current Opinion in Lipidology 1990; 1: 244-47.
6. 6 Björkhem I, Miettinen T, Reihnér E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res 1987; 28: 1137-43.
7. 7 Eaton RP, Nye WHR. The relationship between insulin secretion and triglyceride concentration in endogenous lipemia. J Lab Clin Med 1973; 81: 682-95.
8. 8 Laker ME, Mayes PA. Investigations into the direct effects of insulin on the hepatic ketogenesis, lipoprotein secretion and pyruvate dehydrogenase activity. Biochem Biophys Acta 1984; 795: 427-30.
9. 9 Topping DL, Mayes PA. Insulin and non-esterified fatty acids. Acute regulators of lipogenesis in perfused rat liver. Biochem J 1982; 204: 433-39.
10. 10 Lewis GV, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinaemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 833-41.
11. 11 Scoppola A, Testa G, Frontoni S et al. Effects of insulin on cholesterol synthesis in type II diabetes patients. Diabetes Care 1989; 18: 1362-69.
12. 12 Asplund-Carlson A, Carlson LA. Studies in hypertriglyceridaemia I. Serum triglyceride distribution and its correlates in randomly selected Swedish middle-aged men. J Intern Med 1994; 236: 57-64.
13. 13 Asplund-Carlson A. Studies in hypertriglyceridaemia II. Clinical characteristics linked with the hypertriglyceridaemic state in randomly selected Swedish men. Nutr Metab Cardiovasc Dis 1994; 4: 88-95.
14. 14 Asplund-Carlson A. Studies in hypertriglyceridaemia III. Glucose tolerance, insulin sensitivity and indices of adipose tissue lipolysis in randomly selected non-diabetic hypertriglyceridaemic Swedish men. Eur J Clin Invest 1995; 25: 769-76.
15. 15 Asplund-Carlson A, Moritz Å, Ringertz H, Carlson LA. Studies in hypertriglyceridaemia IV. Dietary intake, adipose tissue distribution and composition in randomly selected hyper-and normotriglyceridaemic middle-aged Swedish men. Nutr Metab Cardiovasc Dis 1996; 6: 39-46.
16. 16 Asplund-Carlson A, Hamsten A, Wiman B, Carlson LA. Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo-and hypertriglyceridaemic men. Diabetologia 1993; 36: 817-25.
17. 17 Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF. et al. A common variant in the gene for lipoprotein lipase (Asp→Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995; 15: 468-78.
18. 18 Lund E, Sisfontes L, Reihnér E, Björkhem I. Determination of serum levels of unesterified lathosterol by isotope dilution-mass spectrometry. Scand J Clin Lab Invest 1989; 49: 156-71.
19. 19 World Health Organization Expert Committee. Diabetes Mellitus. Technical Report Series no. 742. Geneva: World Health Organization, 1985.
20. 20 Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973; 52: 1544-68.
21. 21 Ginsberg HN, Le NA, Gibson JC. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss. J Clin Invest 1985; 75: 614-43.
22. 22 Kesaniemi YA, Grundy SM. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man. J Am Med Assoc 1984; 251: 2241-46.
23. 23 Thompson GR, Naomova RP, Watts GF. Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res 1996; 37: 439-47.
24. 24 Miettinen TA. Cholesterol production in obesity. Circulation 1971; 44: 842-50.
25. 25 Nestel PJ, Schreibmann PH, Ahrens EH. Cholesterol metabolism in human obesity. J Clin Invest 1973; 52: 2389-97.